Inovio Pharmaceuticals, Inc. (INO)
1.325
-0.04
(-2.57%)
USD |
NASDAQ |
May 15, 11:58
Inovio Pharmaceuticals Shareholders Equity (Quarterly) : 6.068M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| ADMA Biologics, Inc. | 390.32M |
| Agenus, Inc. | -221.22M |
| Vaxart, Inc. | 94.12M |
| Capricor Therapeutics, Inc. | 278.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 49.78M |
| Total Liabilities (Quarterly) | 43.71M |
| Debt to Equity Ratio | 1.433 |
| Current Ratio | 1.04 |
| Net Debt Paydown Yield | 0.52% |